Original language | English |
---|---|
Pages (from-to) | 1277-1277 |
Number of pages | 1 |
Journal | Blood |
Volume | 114 |
Publication status | Published - Dec 2009 |
Nilotinib 300 Mg Twice Daily Is Effective and Well Tolerated as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia in Chronic Phase: Preliminary Results of the ICORG 0802 Phase 2 Study
M.C. O'Dwyer, E. Kent, M. Parker, R.T. Swords, F. Giles, P. Le Coutre, S. Padmanabhan, B. Moulton, Mary Frances McMullin, S. Langabeer, K. Egan, E. Conneally
Research output: Contribution to journal › Article › peer-review